Modulation of Bone Marrow-Derived Endothelial Progenitor Cell Activity by Protein Tyrosine Phosphatases

Trends in Cardiovascular Medicine

Volumn 18, Issue 5, 2008, Pages 180-186

  Trop, Sébastien ^a   Tremblay, Michel L ^b   Bourdeau, Annie ^b,c  

^a MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c SUNNYBROOK RESEARCH INSTITUTE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; GROWTH FACTOR RECEPTOR; NON RECEPTOR PROTEIN TYROSINE PHOSPHATASE 2; PROTEIN TYROSINE PHOSPHATASE; PROTEIN TYROSINE PHOSPHATASE 1B; PROTEIN TYROSINE PHOSPHATASE INHIBITOR; SCR HOMOLOGY PHOSPHATASE 1; SCR HOMOLOGY PHOSPHATASE 2; UNCLASSIFIED DRUG;

ANGIOGENESIS; BLOOD FLOW; BLOOD VESSEL; BONE MARROW; CELL ACTIVITY; CELL DIFFERENTIATION; CELL FUNCTION; CELL LINEAGE; CELL MATURATION; CELL MOTILITY; CELL RENEWAL; CORONARY ARTERY DISEASE; ENDOTHELIUM CELL; HEART FUNCTION; HEART INFARCTION; HEMATOPOIETIC CELL; HUMAN; LIMB ISCHEMIA; MODULATION; NONHUMAN; PERINATAL PERIOD; PERIPHERAL VASCULAR DISEASE; PRIORITY JOURNAL; REVIEW; STEM CELL;

ANIMALS; BONE MARROW CELLS; CELL DIFFERENTIATION; CORONARY ARTERY DISEASE; ENDOTHELIAL CELLS; HEMATOPOIESIS; HUMANS; PERIPHERAL VASCULAR DISEASES; PROTEIN TYROSINE PHOSPHATASES; SIGNAL TRANSDUCTION; STEM CELLS;

EID: 51249095846     PISSN: 10501738     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tcm.2008.07.001     Document Type: Review

References (65)

1. Akashi K. Lineage promiscuity and plasticity in hematopoietic development. Ann N Y Acad Sci 1044 (2005) 125-131
2. Asahara T., Masuda H., Takahashi T., et al. Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ Res 85 (1999) 221-228
3. Bourdeau A., Dube N., and Tremblay M.L. Cytoplasmic protein tyrosine phosphatases, regulation and function: the roles of PTP1B and TC-PTP. Curr Opin Cell Biol 17 (2005) 203-209
4. Bourdeau A., Dube N., Heinonen K.M., et al. TC-PTP-deficient bone marrow stromal cells fail to support normal B lymphopoiesis due to abnormal secretion of interferon-gamma. Blood 109 (2007) 4220-4228
5. Boyle A.J., Schulman S.P., Hare J.M., and Oettgen P. Is stem cell therapy ready for patients? Stem cell therapy for cardiac repair. Ready for the Next Step. Circulation 114 (2006) 339-352
6. Buckley D.A., Cheng A., Kiely P.A., et al. Regulation of insulin-like growth factor type I (IGF-I) receptor kinase activity by protein tyrosine phosphatase 1B (PTP-1B) and enhanced IGF-I-mediated suppression of apoptosis and motility in PTP-1B-deficient fibroblasts. Mol Cell Biol 22 (2002) 1998-2010
7. Chan R.J., Li Y., Hass M.N., et al. Shp-2 heterozygous hematopoietic stem cells have deficient repopulating ability due to diminished self-renewal. Exp Hematol 34 (2006) 1230-1239
8. Chavakis E. IL-8: a new player in the homing of endothelial progenitor cells to ischemic myocardium. J Mol Cell Cardiol 40 (2006) 442-445
9. Chernock R.D., Cherla R.P., and Ganju R.K. SHP2 and cbl participate in alpha-chemokine receptor CXCR4-mediated signaling pathways. Blood 97 (2001) 608-615
10. Cleland J.G., Freemantle N., Coletta A.P., and Clark A.L. Clinical trials update from the American Heart Association: REPAIR-AMI, ASTAMI, JELIS, MEGA, REVIVE-II, SURVIVE, and PROACTIVE. Eur J Heart Fail 8 (2006) 105-110
11. Cohen J., Oren-Young L., Klingmuller U., and Neumann D. Protein tyrosine phosphatase 1B participates in the down-regulation of erythropoietin receptor signalling. Biochem J 377 (2004) 517-524
12. Dentelli P., Rosso A., Balsamo A., et al. C-KIT, by interacting with the membrane-bound ligand, recruits endothelial progenitor cells to inflamed endothelium. Blood 109 (2007) 4264-4271
13. Dimmeler S., and Zeiher A.M. Akt takes center stage in angiogenesis signaling. Circ Res 86 (2000) 4-5
14. Dimmeler S., Aicher A., Vasa M., et al. HMG-CoA reductase inhibitors (statins) increase endothelial progenitor cells via the PI 3-kinase/Akt pathway. J Clin Invest 108 (2001) 391-397
15. Dreger P., Haferlach T., Eckstein V., et al. G-CSF-mobilized peripheral blood progenitor cells for allogeneic transplantation: safety, kinetics of mobilization, and composition of the graft. Br J Haematol 87 (1994) 609-613
16. Dube N., Bourdeau A., Heinonen K.M., Cheng A., Loy A.L., and Tremblay M.L. Genetic ablation of protein tyrosine phosphatase 1B accelerates lymphomagenesis of p53-null mice through the regulation of B-cell development. Cancer Res 65 (2005) 10088-10095
17. Dudley A.C., Thomas D., Best J., and Jenkins A. A VEGF/JAK2/STAT5 axis may partially mediate endothelial cell tolerance to hypoxia. Biochem J 390 (2005) 427-436
18. Elchebly M., Payette P., Michaliszyn E., et al. Increased insulin sensitivity and obesity resistance in mice lacking the protein tyrosine phosphatase-1B gene. Science 283 (1999) 1544-1548
19. Fazel S., Cimini M., Chen L., et al. Cardioprotective c-kit+ cells are from the bone marrow and regulate the myocardial balance of angiogenic cytokines. J Clin Invest 116 (2006) 1865-1877
20. Fazel S.S., Chen L., Angoulvant D., et al. Activation of c-kit is necessary for mobilization of reparative bone marrow progenitor cells in response to cardiac injury. FASEB J 22 (2008) 930-940
21. Gill M., Dias S., Hattori K., et al. Vascular trauma induces rapid but transient mobilization of VEGFR2(+)AC133(+) endothelial precursor cells. Circ Res 88 (2001) 167-174
22. Goukassian D.A., Qin G., Dolan C., et al. Tumor necrosis factor-alpha receptor p75 is required in ischemia-induced neovascularization. Circulation 115 (2007) 752-762
23. Gu F., Dube N., Kim J.W., et al. Protein tyrosine phosphatase 1B attenuates growth hormone-mediated JAK2-STAT signaling. Mol Cell Biol 23 (2003) 3753-3762
24. Guo D.Q., Wu L.W., Dunbar J.D., et al. Tumor necrosis factor employs a protein-tyrosine phosphatase to inhibit activation of KDR and vascular endothelial cell growth factor-induced endothelial cell proliferation. J Biol Chem 275 (2000) 11216-11221
25. Haj F.G., Markova B., Klaman L.D., Bohmer F.D., and Neel B.G. Regulation of receptor tyrosine kinase signaling by protein tyrosine phosphatase-1B. J Biol Chem 278 (2003) 739-744
26. Hattori K., Dias S., Heissig B., et al. Vascular endothelial growth factor and angiopoietin-1 stimulate postnatal hematopoiesis by recruitment of vasculogenic and hematopoietic stem cells. J Exp Med 193 (2001) 1005-1014
27. Hattori K., Heissig B., Wu Y., et al. Placental growth factor reconstitutes hematopoiesis by recruiting VEGFR1(+) stem cells from bone-marrow microenvironment. Nat Med 8 (2002) 841-849
28. Heeschen C., Aicher A., Lehmann R., et al. Erythropoietin is a potent physiologic stimulus for endothelial progenitor cell mobilization. Blood 102 (2003) 1340-1346
29. Heinonen K.M., Dube N., Bourdeau A., Lapp W.S., and Tremblay M.L. Protein tyrosine phosphatase 1B negatively regulates macrophage development through CSF-1 signaling. Proc Natl Acad Sci U S A 103 (2006) 2776-2781
30. Hilfiker-Kleiner D., Hilfiker A., Fuchs M., et al. Signal transducer and activator of transcription 3 is required for myocardial capillary growth, control of interstitial matrix deposition, and heart protection from ischemic injury. Circ Res 95 (2004) 187-195
31. Humpert P.M., Djuric Z., Zeuge U., et al. Insulin stimulates the clonogenic potential of angiogenic endothelial progenitor cells by IGF-1 receptor dependent signalling. Mol Med 14 (2008) 301-308
32. Kawamoto A., and Losordo D.W. Endothelial progenitor cells for cardiovascular regeneration. Trends Cardiovasc Med 18 (2008) 33-37
33. Khmelewski E., Becker A., Meinertz T., and Ito W.D. Tissue resident cells play a dominant role in arteriogenesis and concomitant macrophage accumulation. Circ Res 95 (2004) E56-E64
34. Kim C.H., Qu C.K., Hangoc G., et al. Abnormal chemokine-induced responses of immature and mature hematopoietic cells from motheaten mice implicate the protein tyrosine phosphatase SHP-1 in chemokine responses. J Exp Med 190 (1999) 681-690
35. Kocher A.A., Schuster M.D., Bonaros N., et al. Myocardial homing and neovascularization by human bone marrow angioblasts is regulated by IL-8/Gro CXC chemokines. J Mol Cell Cardiol 40 (2006) 455-464
36. Kollet O., Dar A., Shivtiel S., et al. Osteoclasts degrade endosteal components and promote mobilization of hematopoietic progenitor cells. Nat Med 12 (2006) 657-664
37. Kong D., Melo L.G., Gnecchi M., et al. Cytokine-induced mobilization of circulating endothelial progenitor cells enhances repair of injured arteries. Circulation 110 (2004) 2039-2046
38. Li H., Fredriksson L., Li X., and Eriksson U. PDGF-D is a potent transforming and angiogenic growth factor. Oncogene 22 (2003) 1501-1510
39. Lorenz U., Bergemann A.D., Steinberg H.N., et al. Genetic analysis reveals cell type-specific regulation of receptor tyrosine kinase c-Kit by the protein tyrosine phosphatase SHP1. J Exp Med 184 (1996) 1111-1126
40. Lu X., Chen J., Sasmono R.T., et al. T-cell protein tyrosine phosphatase, distinctively expressed in activated-B-cell-like diffuse large B-cell lymphomas, is the nuclear phosphatase of STAT6. Mol Cell Biol 27 (2007) 2166-2179
41. Mannell H., Hellwig N., Gloe T., et al. Inhibition of the tyrosine phosphatase SHP-2 suppresses angiogenesis in vitro and in vivo. J Vasc Res 45 (2008) 153-163
42. Minamino K., Adachi Y., Okigaki M., et al. Macrophage colony-stimulating factor (M-CSF), as well as granulocyte colony-stimulating factor (G-CSF), accelerates neovascularization. Stem Cells 23 (2005) 347-354
43. Nienaber C.A., Petzsch M., Kleine H.D., et al. Effects of granulocyte-colony-stimulating factor on mobilization of bone-marrow-derived stem cells after myocardial infarction in humans. Nat Clin Pract Cardiovasc Med 3 Suppl 1 (2006) S73-S77
44. Paulson R.F., Vesely S., Siminovitch K.A., and Bernstein A. Signalling by the W/Kit receptor tyrosine kinase is negatively regulated in vivo by the protein tyrosine phosphatase Shp1. Nat Genet 13 (1996) 309-315
45. Persson C., Savenhed C., Bourdeau A., et al. Site-selective regulation of platelet-derived growth factor beta receptor tyrosine phosphorylation by T-cell protein tyrosine phosphatase. Mol Cell Biol 24 (2004) 2190-2201
46. Rabbany S.Y., Heissig B., Hattori K., and Rafii S. Molecular pathways regulating mobilization of marrow-derived stem cells for tissue revascularization. Trends Mol Med 9 (2003) 109-117
47. Ribatti D. Hemangioblast does exist. Leuk Res 32 (2008) 850-854
48. Salmond R.J., and Alexander D.R. SHP2 forecast for the immune system: fog gradually clearing. Trends Immunol 27 (2006) 154-160
49. Seki Y., Kai H., Shibata R., et al. Role of the JAK/STAT pathway in rat carotid artery remodeling after vascular injury. Circ Res 87 (2000) 12-18
50. Sharlow E.R., Pacifici R., Crouse J., et al. Hematopoietic cell phosphatase negatively regulates erythropoietin-induced hemoglobinization in erythroleukemic SKT6 cells. Blood 90 (1997) 2175-2187
51. Shepherd R.M., Capoccia B.J., Devine S.M., et al. Angiogenic cells can be rapidly mobilized and efficiently harvested from the blood following treatment with AMD3100. Blood 108 (2006) 3662-3667
52. Simoncic P.D., Bourdeau A., Lee-Loy A., et al. T-cell protein tyrosine phosphatase (Tcptp) is a negative regulator of colony-stimulating factor 1 signaling and macrophage differentiation. Mol Cell Biol 26 (2006) 4149-4160
53. Socinski M.A., Cannistra S.A., Elias A., et al. Granulocyte-macrophage colony stimulating factor expands the circulating haemopoietic progenitor cell compartment in man. Lancet 1 (1988) 1194-1198
54. Sugano M., Tsuchida K., Maeda T., and Makino N. SiRNA targeting SHP-1 accelerates angiogenesis in a rat model of hindlimb ischemia. Atherosclerosis 191 (2007) 33-39
55. Takahashi T., Kalka C., Masuda H., et al. Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization. Nat Med 5 (1999) 434-438
56. Tan Y., Shao H., Eton D., et al. Stromal cell-derived factor-1 enhances pro-angiogenic effect of granulocyte-colony stimulating factor. Cardiovasc Res 73 (2007) 823-832
57. Thum T., Hoeber S., Froese S., et al. Age-dependent impairment of endothelial progenitor cells is corrected by growth-hormone-mediated increase of insulin-like growth-factor-1. Circ Res 100 (2007) 434-443
58. Tsui F.W., Martin A., Wang J., and Tsui H.W. Investigations into the regulation and function of the SH2 domain-containing protein-tyrosine phosphatase, SHP-1. Immunol Res 35 (2006) 127-136
59. Urbich C., Aicher A., Heeschen C., et al. Soluble factors released by endothelial progenitor cells promote migration of endothelial cells and cardiac resident progenitor cells. J Mol Cell Cardiol 39 (2005) 733-742
60. Urbich C., and Dimmeler S. Endothelial progenitor cells functional characterization. Trends Cardiovasc Med 14 (2004) 318-322
61. Vercauteren M., Remy E., Devaux C., et al. Improvement of peripheral endothelial dysfunction by protein tyrosine phosphatase inhibitors in heart failure. Circulation 114 (2006) 2498-2507
62. Walter D.H., Haendeler J., Reinhold J., et al. Impaired CXCR4 signaling contributes to the reduced neovascularization capacity of endothelial progenitor cells from patients with coronary artery disease. Circ Res 97 (2005) 1142-1151
63. Ward A.C., Oomen S.P., Smith L., et al. The SH2 domain-containing protein tyrosine phosphatase SHP-1 is induced by granulocyte colony-stimulating factor (G-CSF) and modulates signaling from the G-CSF receptor. Leukemia 14 (2000) 1284-1291
64. You-Ten K.E., Muise E.S., Itie A., et al. Impaired bone marrow microenvironment and immune function in T cell protein tyrosine phosphatase-deficient mice. J Exp Med 186 (1997) 683-693
65. Yu M., Luo J., Yang W., et al. The scaffolding adapter Gab2, via Shp-2, regulates kit-evoked mast cell proliferation by activating the Rac/JNK pathway. J Biol Chem 281 (2006) 28615-28626